TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Morepen Laboratories Limited ( (IN:MOREPENLAB) ) just unveiled an announcement.
Morepen Laboratories Limited has announced the publication of its unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2025. These results were approved by the Board of Directors on November 14, 2025, and have been published in the Financial Express and Jansatta newspapers. The announcement reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its market perception and investor confidence.
More about Morepen Laboratories Limited
Morepen Laboratories Limited operates in the pharmaceutical industry, focusing on the manufacturing and marketing of active pharmaceutical ingredients (APIs), formulations, and diagnostics. The company is known for its strong presence in the health and wellness market, catering to both domestic and international markets.
Average Trading Volume: 271,375
Technical Sentiment Signal: Sell
Current Market Cap: 25.83B INR
For detailed information about MOREPENLAB stock, go to TipRanks’ Stock Analysis page.